Intelligence Platform

Patents

Browse 68 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 10898583

Harnessing quantum dots to study, visualize, and promote immune tolerance

The Government of the United States of America, as represented by the Secretary of the Navy · Granted Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10894816

Use of IL-15 to increase thymic output and to treat lymphopenia

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Jan 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10865389

DNA vaccines against foot-and-mouth disease virus

The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Tue Dec 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10858633

Method for producing foot-and-mouth disease virus (FMDV) viral proteins utilizing a modifi

The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10858634

Vaccines and pharmaceutical compositions against foot-and-mouth disease virus

granted patent

US 10849970

Antibody evolution immunogens

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10829770

Fusion proteins containing luciferase and a polypeptide of interest

The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10828364

Method for reducing a myeloid derived suppressor cell population with cationic lipid vacci

THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SEC. OF THE DEPT. OF HEALTH AND HUMAN SERVICES · Granted Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10808225

Use of PDL1 expressing cells to convert T cells into regulatory T cells

The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10793865

Transferrable mechanism of generating inducible, BAR domain protein-mediated bacterial out

The Government of the United States of America, as represented by the Secretary of the Navy · Granted Tue Oct 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10780185

Multifunctional nanoparticle bioconjugates for photoacoustic-based recording of cellular m

The Government of the United States of America, as represented by the Secretary of the Navy · Granted Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10724007

Development of dengue virus vaccine components

The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10695414

Modulation of replicative fitness by deoptimization of synonymous codons

THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10604548

Minicircle DNA vector vaccine platform for foot-and-mouth disease and methods thereof

The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10584355

Chimpanzee adenoviral vector-based filovirus vaccines

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10568956

Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominan

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10557118

Compositions and methods for prevention or treatment of neoplastic disease in a mammalian

The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10513542

Minicircle DNA vector vaccine platform for foot-and-mouth disease and methods thereof

The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10507187

Regenerative tissue grafts and methods of making same

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Dec 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10494435

Human monoclonal antibodies specific for CD22

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10471142

Combination therapy using immunoglobulin and C1-Inhibitor

THE GOVERNMENT OF THE UNITED STATES OF AMERICA · Granted Tue Nov 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10449231

Compositions and methods for dengue virus chimeric constructs in vaccines

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10435695

Fusion protein comprising Gaussia luciferase, translation interrupter sequence, and interf

The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10400031

Identification of antibodies specific for lyssaviruses and methods of their use

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted